Medical Key Opinion Leaders In Preeclampsia Join Pluristem Therapeutics (PSTI)'s Steering Committee
2/11/2014 9:22:47 AM
HAIFA, Israel, Feb. 11, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, today announced it has formed a Preeclampsia Steering Committee to advance its PLacental eXpanded (PLX) cell therapies for the treatment of preeclampsia.
Help employers find you! Check out all the jobs and post your resume.
comments powered by